"RP-3467, our potential best-in-class Polθ ATPase inhibitor, has demonstrated highly compelling preclinical results, ...

An innovative new database, the Open Source Munitions Portal (OSMP), identifies and shows remnants of explosive devices in ...

Researchers have developed a breakthrough technology that uses light to visualize nanoscale glass microcapillary tips, ...

Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with common diseases, ...

Developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy.Expanding its ...

CHICAGO, Oct. 1, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will expand its suite of Nikkei 225 futures contracts with the addition of yen- and U.S ...

Developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy.Expanding its pipeline to include non-oncology products, an opportunistic ...

Stratasys Ltd. (NASDAQ: SSYS) today announced the launch of its TechStyle™ Fabric Alignment Station, the next milestone in the evolution of Stratasys 3DFashion™ technology. This solution is designed ...

The 26-kilowatt LWS combines precision optical and laser hardware ... Leonardo DRS Investor Relations Contacts Steve Vather Senior Vice President, Investor Relations and Corporate Finance +1 703 409 ...

The Spider Demon Mother from Demon Slayer left an indelible mark on the series, not just as a formidable antagonist, but as ...

Drugmakers and insurers are exploring different payment schemes for expensive, potentially curative treatments, particularly ones tied to patient response.